Prospects for vaccination against equine grass sickness.

The research article focuses on the potential for the development of a vaccine against the Equine Grass Sickness (EGS) disease, which is believed to be triggered by a toxin produced by the bacterium Clostridium botulism type C in the gastrointestinal tract of horses.

Equine Grass Sickness

• This study discusses Equine Grass Sickness (EGS), a lethal disease that primarily affects horses. EGS is suspected to be caused by a specific toxin produced locally within a horse’s gastrointestinal tract, which is linked to a toxico-infectious form of botulism. Although the precise cause isn’t fully understood, the bacterium Clostridium botulism type C is believed to play a significant role.
• The disease has been studied both historically and in contemporary science, throwing up consistent theories about its etiology across periods of research. This paper discusses the disease in the context of both its historical and clinical aspects.

Evidence and Aetiological Theories

• The article also reviews the available scientific literature that supports the theory of the involvement of Clostridium botulism type C catered botulism in the development of EGS. References from various studies, dated as far back as 1923 to as recent as 2014, provide evidence for this theory.
• In addition to assessing previously established theories, the paper also introduces new perspectives on the aetiology of EGS. It highlights the epidemiological features of the disease, which can help improve understanding of its cause and transmission.

Vaccination Strategies

• A significant portion of the article is dedicated to the exploration of possible strategies for the development of an EGS vaccine. This is considering the disease’s suspected infectious nature, and that prevention, in this case vaccination, could potentially be the most effective strategy.
• The development of an effective EGS vaccine could radically improve the survival and quality of life for affected horses. The research convened in this meeting attempts to synthesize their current understanding of the disease to propose viable vaccination techniques.